NCT05260866|Completed
Impact of the COVID-19 Pandemic on Mental Health Service Utilization in Children and Adolescents
MENTALPED
Loading search results
MENTALPED
Sponsor study identifier
observational
500,000
1 country
1
Study Start
July 1, 2021
Actual (reported)Primary Completion
June 30, 2022
Actual (reported)Study Completion
June 30, 2022
Actual (reported)Mental health consequences of the COVID-19 pandemic may be vast and may potentially overwhelm the mental health system in a long-lasting manner. Evaluating the effects of the COVID-19 pandemic on mental health in vulnerable groups such as children and adolescents has become an immediate priority. The aim of this study is to evaluate the impact of COVID-19 pandemic on use of mental health resources namely 1) prescriptions of psychotropic medications and 2) mental health-related outpatient visits, hospitalizations and emergency department visits in children and adolescents in France. Secondary aim is to evaluate the impact of the pandemic on episodes of fatal and non-fatal self-harm episodes in the same population. This will be a population-based cohort study using data from healthcare claims, administrative medical and outpatient drug dispensation databases in France between January 1, 2016 and June 1, 2021. Findings will inform on the risk of upcoming outbreaks of mental disorders that can result in significant morbidity and mortality and guide timely targeted actions to improve mental health outcomes and wellbeing in the youngest.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1, 2021
Actual (reported)February 17, 2022
Actual (reported)March 2, 2022
Actual (reported)June 30, 2022
Actual (reported)June 30, 2022
Actual (reported)To evaluate the impact of COVID-19 pandemic on use of mental health resources
prescriptions of psychotropic medications; mental health-related outpatient visits; mental health-related hospitalizations and emergency department visits
1 year
To evaluate the impact of COVID-19 pandemic on episodes of fatal and non-fatal self-harm episodes in children and adolescents in France
1 year
No intervention
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Children and adolescents aged from 6 to 18 years
Robert Debre Hospital - Assistance Publique Hopitaux de Paris
Paris, 75019, France
Valtuille Z, Acquaviva E, Trebossen V, Ouldali N, Bourmaud A, Sclison S, Gomez A, Revet A, Peyre H, Delorme R, Kaguelidou F. Prescription Trends of Medications Used to Treat Sleep Disturbances in School-Aged Children: An Interrupted Time-Series Analysis in France, 2016-2023. J Pediatr. 2025 May;280:114502. doi: 10.1016/j.jpeds.2025.114502. Epub 2025 Feb 5.
Florentia Kaguelidou, MD, PhD
Assistance Publique - Hôpitaux de Paris
500,000 participants (actual enrollment reported by the registry).
First Submitted
February 17, 2022
First Posted
March 2, 2022
Study Start
July 1, 2021
Actual (reported)Improving Mental Health in School-age Children Through the Kids' Empowerment Program (KEP)
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2022
Actual (reported)Study Completion
June 30, 2022
Actual (reported)Last Updated
February 23, 2023
Record last verified: 2022-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: